SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-18-013827
Filing Date
2018-12-11
Accepted
2018-12-11 16:47:04
Documents
3
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT mnpr_1109201810-qa.htm 10-Q/A 47416
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit_31-1.htm EX-31.1 6648
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit_31-2.htm EX-31.2 6174
  Complete submission text file 0001654954-18-013827.txt   61200
Mailing Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062
Business Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062 6143958936
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE
Type: 10-Q/A | Act: 34 | File No.: 000-55866 | Film No.: 181229245
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences